CLCN3 and breast carcinoma: Encouragingly, the top resistance gene hit, CLCN3 (shRNA depleted 4.45‐fold, File S1), encodes for transporter chloride channel 3 and is a known mediator of multidrug resistance, including paclitaxel and docetaxel resistance in breast cancer cells [24, 25, 26].